Medtronic Inc (MDT) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Medtronic Inc (MDT)

90.68

+1.27 (1.42%)

as of Aug 11, 2026, 8:00:00 pm Market Open.

182 watching

Investor Insights

Aug 11, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Medtronic Inc (MDT) appears to be in a favorable position in the short to medium term according to expert reviews. The company is seen as benefiting from ongoing market dynamics, particularly as it capitalizes on advancements in AI and a supportive demographic trend involving Baby Boomers. However, concerns regarding its competitive edge have been raised, especially in comparison to peers like Boston Scientific who possess stronger R&D capabilities. Despite these challenges, experts believe that Medtronic's diversification across various medical devices sets it apart from competitors focused solely on specific areas like knee devices. The stock is viewed as a potential trade opportunity rather than a long-term investment, buoyed by successful product launches and an attractive price-to-earnings ratio that could support the stock's performance for the next 12-18 months, but not much beyond that.

Consensus

Positive

Valuation

Undervalued

Similar

Abbott,ABT

TOP PICK

He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.

BUY

Likes medical devices sector. Of all the sectors, medical equipment is one of the tops. Regardless of what is going on in the economies , medical devices will continue to sell. He owns Zoll Medical (ZOLL-Q) instead, which has more growth potential. Thinks there is more upside potential in the small/mid-cap size names.

BUY

PE of about 20 and anticipated growth rate of about 14%. Have a lot of intellectual property. Reasonably attractive.

DON'T BUY

His model price is $41.45 so it is a negative 23%-24% differential. This is one of those stocks that is perpetually overvalued.

BUY

Likes a lot of the big US healthcare stocks. Valuation is reasonable.

BUY ON WEAKNESS

On his watch list as a possible investment. Valuation has been hurt but the fundamentals have not changed much. The long-term outlook for their products is very good.

TOP PICK

A high quality, growth company. Good price. The leading medical technology company in the world.

TOP PICK

Solid earnings. Feels their new stent will be successful next year.

DON'T BUY

Interesting company. Market is very strong for their products. Stock isn't cheap. Has been growing slowely

DON'T BUY

Valuation is a little bit ahead of the stock. Very good management.

DON'T BUY

Competition. Too expensive at 30 X earnings.

BUY ON WEAKNESS

Great company. Buy in the mid to low $20's.

TOP PICK

Good company. Not a cheap stock. A cash machine.

BUY

Good price now. Good mngmnt.

PAST TOP PICK

Good acquisition. Fairly expensive, but the dominant player. No debt. Good dividends.

Showing 106 to 120 of 125 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Christine Poole

Davis Rea

Eric Nuttall

Ninepoint Partners

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Jim Lebenthal

Cerity Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Medtronic Inc (MDT)